Director of Regulatory Affairs

At Avalo (ahh-vah-lowe), we are 100% focused on developing treatments for immune-mediated inflammatory diseases with large unmet needs. Our strategy is to develop medicines that target the IL-1β pathway, the central driver of the inflammatory process.

Avalon Therapeutics seeks a strategic and execution-focused Director of Regulatory Affairs to provide global regulatory leadership for abdakibart (AVTX-009) as it advances into Phase 3 and beyond.

• Design, lead, and implement global regulatory strategies to support the development, registration, and lifecycle management of assigned programs.
• Serve as the Regulatory Affairs representative on cross-functional project teams and provide proactive, strategic guidance to advance program objectives.
• Evaluate evolving regulatory requirements, competitive developments, and emerging scientific trends, and assess potential impacts on development strategy.
• Identify regulatory risks, develop mitigation plans, and communicate recommendations to project teams and senior leadership.
• Contribute to regulatory development plans supporting advancement throughout development to commercialization.
• Collaborate with senior regulatory leadership on major strategic initiatives, including FDA and global health authority meetings, registration strategy, BLA planning, and labeling activities.
• Lead the planning, preparation, review, and submission of regulatory documents throughout the product lifecycle.
• Provide hands-on leadership for a broad range of U.S. and global regulatory submissions, such as DSURs, protocol amendments, information amendments, INDs, CTAs, labeling, etc.
• Ensure submissions are scientifically accurate, strategically aligned, compliant, and delivered on schedule.
• Lead and coordinate routine regulatory submissions independently while supporting more complex registration activities under the guidance of senior regulatory leadership.
• Support preparation and maintenance of future NDA/BLA and ex-US marketing application activities.
• Serve as a key point of contact with FDA and support interactions with ex-US regulatory agencies.
• Lead preparation of regulatory briefing materials, meeting requests, information packages, and responses to agency inquiries.
• Participate in and support regulatory authority meetings, teleconferences, and written communications.
• Coordinate regulatory intelligence and ensure project teams remain informed of evolving agency expectations.
• Manage external regulatory consultants and CRO partners supporting global CTA submissions, maintenance activities, and health authority responses.
• Drive accountability and alignment across functions to meet aggressive development timelines.

• Participate in departmental initiatives, task forces, and special projects.
• Support diligence activities and regulatory assessments as needed.
• Perform other duties as assigned.

• Bachelor’s degree in a scientific discipline required.
• Advanced degree (MS, PharmD, PhD, or equivalent) preferred.
• 10–15 years of Regulatory Affairs experience within the biotechnology and/or pharmaceutical industry.
• Minimum of 5 years of experience within a small or emerging biotechnology company preferred.
• Demonstrated experience supporting late-stage clinical development programs.
• Proven experience authoring, reviewing, and managing a broad range of regulatory submissions, including INDs, CTAs, amendments, IND Safety Reports, DSURs, annual reports, and briefing packages.
• Experience interacting directly with FDA and supporting ex-US regulatory activities.
• Experience managing CROs and external consultants supporting global regulatory submissions and agency responses.
• Experience supporting preparation for major regulatory milestones such as End-of-Phase 2 meetings, Phase 3 development programs, BLA preparation, and registration planning preferred.
• Deep understanding of global drug development and regulatory requirements for biologics.
• Strong knowledge of FDA regulations and familiarity with EMA and other international regulatory frameworks.
• Ability to thrive in a fast-paced biotechnology environment while managing multiple priorities and deadlines.
• Experience working in a cross-functional team.

Less than 5% travel.

Avalo Therapeutics is a clinical-stage biotechnology company dedicated to developing therapeutics targeting the IL-1β pathway for immune-mediated inflammatory diseases. Our lead asset, abdakibart, is an anti-IL-1β monoclonal antibody that recently demonstrated positive topline data in a Phase 2 trial in hidradenitis suppurativa. We also advance AVTX-010, a long-acting next-generation anti-IL-1β mAb. For more information, visit